Panel Backs FDA’s Proposed Approach On Pulse Ox Research

An FDA advisory panel supported an FDA proposal calling for larger clinical trials of pulse oximeters to improve their accuracy in people with darker skin tones.

More from Clinical Trials

More from R&D